Systemic Inflammatory Response Syndrome (SIRS): Molecular Pathophysiology and Gene Therapy

DOI Web Site PubMed 被引用文献11件 参考文献161件 オープンアクセス
  • Matsuda Naoyuki
    Department of Pharmacology, School of Medicine, University of Toyama, Japan
  • Hattori Yuichi
    Department of Pharmacology, School of Medicine, University of Toyama, Japan

この論文をさがす

説明

In recent years, extensive basic science research has led to a clear understanding of the molecular mechanisms contributing to the pathophysiology of sepsis. Sepsis is now defined as a systemic inflammatory response syndrome (SIRS) in which there is an identifiable focus of infection. SIRS can be also precipitated by non-infective events such as trauma, pancreatitis, and surgery. As a consequence of an overactive SIRS response, the function of various organ systems may be compromised, resulting in multiple organ dysfunction syndrome (MODS) and death. Production and activation of multiple proinflammatory genes are likely to play a key role in the pathogenesis of MODS development. This review article focuses on the molecular mechanisms and components involved in the pathogenesis of severe sepsis. This includes cellular targets of sepsis-inducing bacterial products and their signaling pathways with a major emphasis on transcription factors and new therapeutic approaches to severe sepsis.<br>

収録刊行物

被引用文献 (11)*注記

もっと見る

参考文献 (161)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ